RESPONSE TO ANTI-THYMOCYTE GLOBULIN (ATG) IN PATIENTS WITH APLASTIC ANEMIA (AA): A SINGLE-CENTRE EXPERIENCE OVER THE LAST 28 YEARS

被引：0
|
作者：
Oelmueller, M. [1 ]
Alashkar, F. [1 ]
Herich-Terhuerne, D. [1 ]
Duehrsen, U. [1 ]
Roeth, A. [1 ]
机构：
[1] Univ Hosp Essen, Dept Hematol, Essen, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P582
引用
收藏
页码：226 / 226
页数：1
相关论文
共 50 条
  • [31] Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia
    Onishi, Yasushi
    Mori, Takehiko
    Yamazaki, Hirohito
    Takenaka, Katsuto
    Yamaguchi, Hiroki
    Shingai, Naoki
    Ozawa, Yukiyasu
    Iida, Hiroatsu
    Ota, Shuichi
    Uchida, Naoyuki
    Miyamoto, Toshihiro
    Katayama, Yuta
    Kato, Jun
    Yoshioka, Satoshi
    Onizuka, Makoto
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 217 - 228
  • [32] Management of severe aplastic anaemia in childhood: a single-centre experience over 30 years
    Sovinz, P.
    Lackner, H.
    Schwinger, W.
    Benesch, M.
    Nebl, A.
    Urban, C.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S272 - S272
  • [33] ANTI-THYMOCYTE GLOBULIN TREATMENT IN SEVERE APLASTIC-ANEMIA - LONG-TERM FOLLOW UP OF 13 RESPONDER PATIENTS
    DEVERGIE, A
    GLUCKMAN, E
    FAILLE, A
    BOIRON, M
    BERNARD, J
    BLUT, 1980, 41 (03): : 171 - 174
  • [34] Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin
    van der Hem, Joost G. K.
    de Wreede, Liesbeth C.
    Brand, Anneke
    Veelken, Hendrik
    Falkenburg, J. H. Frederik
    Halkes, Constantijn J. M.
    HAEMATOLOGICA, 2017, 102 (10) : E382 - E383
  • [35] POLYAMINE (PA) CONCENTRATIONS AS MARKERS OF RESPONSE TO ANTI-THYMOCYTE GLOBULIN (ATG) THERAPY AND OF REJECTION IN HEART-TRANSPLANT PATIENTS
    WOMBLE, JR
    LARSON, DF
    COPELAND, JG
    MAMMANA, RB
    RUSSELL, DH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 212 - 212
  • [36] INDUCTION THERAPY WITH ANTI-THYMOCYTE GLOBULIN VERSUS BASILIXIMAB IN HEART TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE
    Manfredini, V.
    Pettit, S.
    Lewis, C.
    Brahmbhatt, D. H.
    Parameshwar, J.
    Kydd, A.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 14 - 14
  • [37] Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemia
    Ben Abdeljelil, Nour
    Ben Yaiche, Insaf
    Ouerghi, Rihab
    Torjemane, Lamia
    Belloumi, Dorra
    Turki, Ines
    Mekni, Sabrine
    Kanoun, Rimel Yousr
    Ben Othman, Tarek
    Ladeb, Saloua
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (08) : 527 - 538
  • [38] A Single-Centre Experience of First-Line Romiplostim and Immunosuppressive Therapy in Patients With Aplastic Anemia
    Dhingra, Gaurav
    Rajoreya, Ashok
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [39] Patients with severe aplastic anemia can be allografted succesfully without anti-thymocyte globulin, using a non-myeloablative conditioning regimen
    Gómez-Almaguer, D
    Vela-Ojeda, J
    Jaime-Pérez, JC
    Gutiérrez-Aguirre, CH
    Cantú-Rodríguez, OG
    Gómez-Rangel, D
    Ruiz-Argüelles, GJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 33 - 33
  • [40] Relationship between plasma rabbit anti-thymocyte globulin level and response to immunosuppressive therapy in patients with severe aplastic anemia: Results of a multicenter, prospective, randomized study
    Narita, Atsushi
    Muramatsu, Hideki
    Xu, Yinyan
    Nishikawa, Eri
    Kawashima, Nozomu
    Okuno, Yusuke
    Nishio, Nobuhiro
    Hama, Asahito
    Yamazaki, Hirohito
    Nakao, Shinji
    Kojima, Seiji
    Takahashi, Yoshiyuki
    BONE MARROW TRANSPLANTATION, 2019, 54 : 29 - 29
12345